Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2025-12-24 @ 4:59 PM
NCT ID:
NCT01526850
Eligibility Criteria:
Inclusion Criteria:
* Extensive cGVHD with skin and/or liver damage developed after allogeneic hematopoietic stem cell transplantation
* cGVHD that do not response to conventional immunosuppressant treatment for two months
* KPS\>= 30
* informed consent from the patient
Exclusion Criteria:
* Extensive cGVHD without skin or liver damage
* With other acute severe complications
* In pregnancy or lactation
* Disease relapses
* With non-hematological malignancy
* Have a history of mental disorder, drug or alcohol abuse over the past five years
* Allergic
* Participate in other clinical trial within three months before the start of this trial
* With bone marrow fibrosis
* Have undergone hematopoietic stem cell transplantation to treat solid tumor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
60 Years
Study:
NCT01526850
Study Brief:
Protocol Section:
NCT01526850